We’re excited to announce the launch of a search for NAF’s first Chief Scientific Officer. This exciting role is new for NAF and will be instrumental in shaping our research funding strategy and deepening our rapidly expanding partnerships in the pharmaceutical space. The Ataxia community is at a pivotal moment in our search for effective treatments. We believe this senior-level hire will help accelerate NAF’s ability to work with our membership and grow participation in research studies and clinical trials going forward.